Results 181 to 190 of about 6,071 (199)

Recurrent Wheezing in Childhood and Palivizumab

American Journal of Respiratory and Critical Care Medicine, 2017
Heather E. Hoch, Joseph M. Collaco
openaire   +2 more sources

Adherence and outcomes: a systematic review of palivizumab utilization

Expert Review of Respiratory Medicine, 2018
Abby Li, Krista L Lanctôt, Bosco Paes
exaly  

Palivizumab and RSVIG

Inpharma Weekly, 1998
openaire   +2 more sources

A review of cost–effectiveness of palivizumab for respiratory syncytial virus

Expert Review of Pharmacoeconomics and Outcomes Research, 2012
Abby Li, Bosco Paes, Krista L Lanctôt
exaly  

A case of anaphylaxis to palivizumab

Annals of Allergy, Asthma & Immunology, 2014
Julia Savitz, Casey Geaney, Taylor A. Banks   +2 more
openaire   +1 more source

PALIVIZUMAB (SYNAGIS)

American Journal of Nursing, 1999
openaire   +1 more source

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry

Journal of Perinatology, 2008
exaly  

Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis

Allergologia Et Immunopathologia, 2015
Manuel Sanchez-Solís, Silvia Gärtner, Luis García-Marcos   +2 more
exaly  

Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV

Pediatrics, 1998
exaly  

Results of clinical surveillance during the Japanese first palivizumab season in 2002–2003

Pediatrics International, 2006
Satoshi Kusuda, Takenobu Koizumi, Masanori Fujimura   +2 more
exaly